Oxford Brain Diagnostics secures FDA 510(k) approval for CDM Insights
Designed using Oxford Brain Diagnostics’ Cortical Disarray Measurement (CDM) technology, CDM Insights is a cloud-native software solution that provides a deeper understanding of the brain’s microstructure from MRI scans
